α-Synuclein Pathology in PRKN-Linked Parkinson's Disease: New Insights from a Blood-Based Seed Amplification Assay
Ann Neurol (2024) 95 (6), 1173-1177 DOI: 10.1002/ana.26917
Distinct tau and alpha-synuclein molecular signatures in Alzheimer’s disease with and without Lewy bodies and Parkinson’s disease with dementia
Acta Neuropathol (2024) 147 (1), 14 DOI: 10.1007/s00401-023-02657-y
Nanoplastics exacerbate Parkinson's disease symptoms in C. elegans and human cells
J Hazard Mater (2024) 465, 133289 DOI: 10.1016/j.jhazmat.2023.133289
Autoclave treatment fails to completely inactivate DLB alpha-synuclein seeding activity
Biochemistry and Biophysics Reports (2023) 34, 101446 DOI: 10.1016/j.bbrep.2023.101446
Histological Examination of Mitochondrial Morphology in a Parkinson's Disease Model
J. Vis. Exp. (196), e65453, doi:10.3791/65453 (2023).
Oligomeric and Fibrillar α-Synuclein Display Persistent Dynamics and Compressibility under Controlled Confinement
ACS Chem Neurosci (2023) 14 (21), 3905-3912 DOI: 10.1021/acschemneuro.3c00470
Seed Amplification Assay as a Diagnostic Tool in Newly-Diagnosed Parkinson's Disease
J Parkinsons Dis (2023) 13 (5), 841-844 DOI: 10.3233/JPD-230065
The G51D SNCA mutation generates a slowly progressive α-synuclein strain in early-onset Parkinson’s disease
Acta Neuropathol Commun (2023) 11 (1), 72 DOI: 10.1186/s40478-023-01570-5
Molecular determinants of the crosstalk between endosomal microautophagy and chaperone-mediated autophagy
Cell Reports (2023) 42 (12), 113529 DOI: 10.1016/j.celrep.2023.113529
Single-domain antibody–based noninvasive in vivo imaging of α-synuclein or tau pathology
Science Advances (2023) 9 (19), eadf3775 DOI: 10.1126/sciadv.adf3775